The brain’s cerebellum may ease alcohol withdrawal symptoms

A shaky hand, a racing heart, a wave of dread; alcohol withdrawal can feel like your body has turned against you. For many people with alcohol use disorder, those early days without alcohol bring symptoms so intense they pull you back to drinking, even when you want to quit.

Researchers at Washington State University now say a surprising part of the brain may help explain that brutal stretch, and may offer a more targeted way to ease it. In a study, the team found that adjusting activity in the cerebellum reduced both movement problems and emotional distress during withdrawal in mice.

The work points to a new treatment path that focuses less on the brain’s reward circuits and more on the brain region long linked to balance and coordination.

Alcohol use disorder affects an estimated 29 million Americans. It is the nation’s third-leading preventable cause of death, behind cigarette smoking and obesity. Fewer than one in five people with AUD maintain long-term sobriety, even with available treatments.

Most addiction research has focused on reward centers that shape craving. This team looked elsewhere, at the cerebellum, a region packed with neurons.

“Half the neurons in the brain are in the cerebellum,” said David Rossi, the study’s senior author and an associate professor in integrative physiology and neuroscience. “It’s increasingly clear this region is involved in far more than just motor control; it plays a role in addiction, emotional regulation and even social engagement.”

In withdrawal, symptoms often come in two painful layers. The body may feel unsteady and clumsy. The mind may feel tense, anxious, and on edge. The researchers aimed at both.

The scientists used mice to model chronic alcohol exposure and withdrawal. Their central idea was simple: long-term drinking changes brain signaling, and the brain starts to “expect” alcohol.

With repeated exposure, the cerebellum’s normal checks and balances shift. The region becomes tuned to operate with alcohol present. When alcohol disappears, the system swings the other way and becomes overactive.

That surge can show up as poor coordination and emotional strain. It can also help explain why drinking again can feel like fast relief, even when it threatens long-term recovery.

“Our research suggests the cerebellum could be a promising therapeutic target to help people get through the most difficult stage of alcohol use disorder,” said Nadia McLean, the study’s lead author and a doctoral researcher in integrative physiology and neuroscience. “By targeting the cerebellum, we were able to ease both the physical motor discoordination and the emotional distress of withdrawal; the symptoms that so often drive people back to drinking.”

The team tested two ways to calm the cerebellum during withdrawal.

First, they used genetic tools to add special receptors to cerebellar neurons. When switched on, these receptors acted like a brake. The approach reduced overactivity and improved motor coordination in withdrawing mice. The researchers viewed this as proof of principle, showing that restoring inhibition in this brain region can ease symptoms.

But that method depends on genetic changes, so it is not a realistic near-term option for people.

The second strategy aimed at something more practical. The researchers tested a synthetic drug known as Compound 6, developed by chemists in Austria. It targets a receptor found only in the cerebellum. That specificity matters because many drugs that act broadly in the brain can cause sedation or other side effects.

In mice experiencing withdrawal, Compound 6 eased anxiety-like distress without affecting the rest of the brain. The compound also showed low abuse potential. Mice not in withdrawal found it aversive, which suggests it does not create the kind of pull that fuels addiction.

“Compound 6 gave us a way to target the cerebellum without genetic modification,” McLean said. “That makes it a much more realistic option for therapy, and it suggests this part of the brain could be a powerful target for treating alcohol withdrawal.”

Withdrawal care often means managing symptoms while a person tries to stay committed to treatment. Even short-term relief can make a difference, especially when fear of withdrawal drives relapse.

“What makes this approach exciting is that we’re looking at ways to target a very specific brain region and receptor, instead of applying a broad treatment that comes with side effects,” Rossi told The Brighter Side of News. “If we can take away the worst part of withdrawal, even temporarily, people may be better able to succeed with counseling or other long-term treatments for AUD.”

The team stressed that human trials remain far off. Still, the study lays groundwork for therapies that aim at a precise brain circuit involved in both movement and emotion.

For anyone who has watched withdrawal derail recovery, the promise is straightforward: make the hardest days less punishing, so more people can stay in the fight.

Targeting the cerebellum could help researchers design withdrawal treatments that focus on specific symptoms, including poor coordination and anxiety-like distress.

A cerebellum-specific drug approach may reduce side effects seen with broader brain-acting medicines, since it aims at a receptor found only in that region.

If future studies confirm similar effects in humans, clinicians might better support early recovery by easing the worst withdrawal period and improving engagement with counseling and long-term care.

The work also broadens addiction research by highlighting the cerebellum’s role in emotional regulation and relapse pressure, not only movement control.

Research findings are available online in the journal Neuropharmacology.

Like these kind of feel good stories? Get The Brighter Side of News' newsletter.